You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 285 No. 22, June 13, 2001 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Medical News & Perspectives
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA

Miscellanea Medica

JAMA. 2001;285:2846.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

  • John P. Howe III, MD, has been appointed president and chief executive officer of Project HOPE, based in Millwood, Va. For the past 15 years, Howe was president of the University of Texas Health Science Center at San Antonio.
  • Michael L. Berman, MD, professor in the Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, at the University of California, Irvine, Medical Center, has been elected president of the Society of Gynecologic Oncologists.
  • David C. Hess, MD, professor of neurology at the Medical College of Georgia (MCG) and executive for the Neurosciences Service Line at the Department of Veterans Affairs Medical Center in Augusta, has been named chair of the MCG Department of Neurology.
  • Delbert A. Fisher, MD, vice president for Science and Innovation at Quest Diagnostics Inc, Teterboro, NJ, and a long-time leader in research in the field of pediatric endocrinology and metabolism, has received the John Howland Award . . . [Full Text of this Article]



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Goal attainment in patients referred to a telephone-based dyslipidemia program
Palmieri et al.
Am J Health Syst Pharm 2005;62:1586-1591.
ABSTRACT | FULL TEXT  

Prevention and Treatment of the Metabolic Syndrome
Daskalopoulou et al.
ANGIOLOGY 2004;55:589-612.
ABSTRACT  

Prevention and Treatment of the Metabolic Syndrome
Daskalopoulou et al.
ANGIOLOGY 2004;55:589-612.
ABSTRACT  

Apolipoprotein C-III, metabolic syndrome, and risk of coronary artery disease
Olivieri et al.
J. Lipid Res. 2003;44:2374-2381.
ABSTRACT | FULL TEXT  

Metabolic Syndrome: Pathophysiology and Implications for Management of Cardiovascular Disease
Reaven
Circulation 2002;106:286-288.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2001 American Medical Association. All Rights Reserved.